Friday, August 20, 2021

Natco faces setback in patent litigation in US for blockbuster cancer drug Imbruvica

Natco faces setback in patent litigation in US for blockbuster cancer drug Imbruvica Natco along with its partner Alvogen are reviewing the judgement and said they will evaluate all options to appeal the judgement.

from Moneycontrol Business News https://ift.tt/3gkFQ1Q

No comments:

Post a Comment

Bajaj Auto shares fall 2% as firm, subsidiary fall prey to ransomware attack

Bajaj Auto shares dipped 2% following a ransomware attack on its systems and subsidiary, Bajaj Auto Technology Ltd, on June 23, 2026. The co...